Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Profit After Tax (2018 - 2025)

TransMedics (TMDX) has 8 years of Profit After Tax data on record, last reported at -$68.1 million in Q4 2025.

  • For Q4 2025, Profit After Tax fell 139.35% year-over-year to -$68.1 million; the TTM value through Dec 2025 reached $12.3 million, up 8334.25%, while the annual FY2025 figure was $190.3 million, 436.06% up from the prior year.
  • Profit After Tax reached -$68.1 million in Q4 2025 per TMDX's latest filing, down from $19.8 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $34.9 million in Q2 2025 and bottomed at -$68.1 million in Q4 2025.
  • Average Profit After Tax over 5 years is -$4.7 million, with a median of -$7.1 million recorded in 2022.
  • The widest YoY moves for Profit After Tax: up 1318.18% in 2024, down 798.55% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$12.7 million in 2021, then skyrocketed by 46.95% to -$6.7 million in 2022, then skyrocketed by 160.6% to $4.1 million in 2023, then tumbled by 798.55% to -$28.4 million in 2024, then tumbled by 139.35% to -$68.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were -$68.1 million in Q4 2025, $19.8 million in Q3 2025, and $34.9 million in Q2 2025.